Drugs Information:
Riluzole
Basic Information
|
||
ID | DDInter1596 | |
Drug Type | small molecule | |
Molecular Formula | C8H5F3N2OS | |
Molecular Weight | 234.198 | |
CAS Number | 1744-22-5 | |
Description | A glutamate antagonist (receptors, glutamate) used as an anticonvulsant (anticonvulsants) and to prolong the survival of patients with amyotrophic lateral sclerosis. Riluzole is marketed as Rilutek by Sanofi. | |
ATC Classification | N07XX02 | |
IUPAC Name | 6-(trifluoromethoxy)-1,3-benzothiazol-2-amine | |
InChI | FTALBRSUTCGOEG-UHFFFAOYSA-N | |
Canonical SMILES | NC1=NC2=C(S1)C=C(OC(F)(F)F)C=C2 | |
Useful Links | DrugBank ChEBI PubChem Substance KEGG Compound KEGG Drug ChemSpider BindingDB PharmGKB Therapeutic Targets Database Guide to Pharmacology Wikipedia ChEMBL ZINC |
Interactions with
Riluzole
Filter:
Severity level | ID | Name | Mechanism | Detail |
---|
Interactions with diseases
Filter:
Severity level | Disease name | Text | References |
---|
Interactions with foods
Filter:
Severity level | Food name | Description | Management | Mechanism | References |
---|
Interactions with compound preparation
Multi-DRUG trade | Multi-DRUG | Drug type | Warning | Note |
---|